On discharge from hospital, patients with type 2 myocardial infarction or myocardial injury and a history of coronary artery disease were less likely than those with type 1 myocardial infarction to be prescribed aspirin (66.2% versus 90.7%), a statin (69.2% versus 86.0%), or an angiotensin converting enzyme inhibitor (52.9% versus 71.3%, P<0.001 for all) (Table 4). The gene discussed is ACE; the disease is coronary artery disorder.